| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
Revenue  | 41 | 37 | 36 | 36 | 41 | 43 | 41 | 39 | 45 | 44 | 68 | 98 | 101 | 84 | 131 | 113 | 93 | 84 | 86 | 70 | 67 | 96 | 95 | 91 | 104 | 112 | 102 | 94 | 99 | 96 | 101 | 55 | 106 | 85 | 59 | 102 | 103 | 81 | 98 | 159 | 144 | 145 | 136 | 141 | 136 | 126 |
| Expenses | 34 | 32 | 33 | 33 | 38 | 35 | 41 | 38 | 39 | 42 | 50 | 59 | 59 | 54 | 77 | 67 | 61 | 57 | 65 | 53 | 55 | 72 | 66 | 68 | 89 | 84 | 84 | 91 | 78 | 87 | 95 | 84 | 95 | 72 | 78 | 74 | 92 | 77 | 76 | 103 | 103 | 108 | 104 | 115 | 102 | 104 |
| EBITDA | 7 | 5 | 3 | 4 | 3 | 8 | 1 | 1 | 6 | 2 | 18 | 40 | 43 | 29 | 54 | 46 | 32 | 27 | 21 | 17 | 12 | 24 | 29 | 23 | 15 | 28 | 18 | 3 | 21 | 9 | 6 | -29 | 11 | 13 | -19 | 28 | 11 | 4 | 22 | 56 | 41 | 37 | 32 | 26 | 34 | 22 |
| Operating Profit % | 17 % | 14 % | 10 % | 10 % | 6 % | 18 % | -1 % | -1 % | 12 % | 4 % | 21 % | 40 % | 39 % | 32 % | 37 % | 40 % | 34 % | 30 % | 19 % | 21 % | 15 % | 24 % | 29 % | 25 % | 10 % | 24 % | 16 % | 2 % | 18 % | 5 % | 3 % | -53 % | 10 % | 13 % | -38 % | 25 % | 6 % | 1 % | 20 % | 34 % | 26 % | 21 % | 20 % | 17 % | 16 % | 15 % |
| Depreciation | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 9 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 | 5 |
| Interest | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 2 | 4 | 4 | 5 | 6 | 6 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 5 | 4 | 5 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 5 | 3 | 3 | 2 | -1 | 3 | -5 | -4 | 0 | -3 | 11 | 34 | 35 | 22 | 46 | 37 | 23 | 19 | 12 | 8 | 4 | 16 | 18 | 14 | 3 | 18 | 7 | -7 | 10 | -2 | -8 | -41 | -1 | 2 | -29 | 16 | 1 | -6 | 12 | 45 | 32 | 28 | 24 | 18 | 26 | 15 |
| Tax | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 4 | 8 | 17 | 5 | 12 | 10 | -15 | 5 | -21 | -2 | 1 | 2 | 4 | 4 | -1 | 6 | 3 | 1 | 2 | 0 | 1 | -3 | 4 | 0 | 0 | 6 | 8 | 0 | 1 | 8 | -1 | 7 | 6 | 6 | 8 | 5 |
| Net Profit | 3 | 2 | 1 | 1 | -2 | 2 | -6 | -4 | -1 | -4 | 7 | 26 | 18 | 17 | 35 | 28 | 39 | 14 | 33 | 10 | 3 | 14 | 15 | 10 | 4 | 12 | 4 | -8 | 8 | -3 | -9 | -38 | -5 | 2 | -29 | 10 | -7 | -6 | 11 | 38 | 33 | 22 | 18 | 12 | 19 | 10 |
| EPS in ₹ | 9.93 | 5.63 | 0.93 | 1.41 | -12.92 | 8.68 | -25.39 | -18.97 | -8.84 | -17.57 | 29.17 | 82.73 | 17.38 | 72.32 | 34.84 | 9.68 | 13.33 | 14.21 | 33.99 | 3.35 | 1.09 | 4.72 | 5.10 | 3.40 | 2.56 | 3.92 | 1.56 | -2.79 | 2.66 | -0.90 | -2.80 | -12.97 | -1.42 | 0.64 | -7.32 | 3.41 | -2.41 | -2.01 | 3.94 | 12.71 | 11.79 | 7.49 | 6.20 | 4.36 | 6.66 | 3.40 |
Fermenta Biotech
Fermenta Biotech
450.05
-10.00
(-2.17%)
Market Cap
1,324.54 Cr
PE Ratio
23.24
Volume
1,53,117.00
Day High - Low
467.00 - 442.00
52W High-Low
580.45 - 248.85
Q1 Quarterly Results are out. Check out the updated financials3 days ago
View
Key Fundamentals
Market Cap
1,324.54 Cr
EPS
24.70
PE Ratio
23.24
PB Ratio
3.33
Book Value
138.15
EBITDA
122.20
Dividend Yield
0.80 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
17.54
Debt to Equity
0.30
Actual
Company News
View All News
Fermenta Biotech declares ₹3.75 dividend
3 days ago
3 days agoFermenta Biotech Limited approved a ₹3.75 per share dividend and reappointed Ms. Rajeshwari Datla at its 74th AGM held on August 11, 2026.
Fermenta Biotech Limited reported consolidated revenue of ₹548 crore in FY26, up 14% YoY, driven by core nutrition and green chemistry segments. Core EBITDA rose 44% to ₹120 crore as real estate income normalized.
Fermenta Biotech reported Q1FY27 PAT of ₹9.5 crore, down 56% YoY. Revenue fell 13% to ₹126.2 crore. India revenue share rose to 47%, while animal nutrition realisations dropped 40%.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,930.00 | #1 4,63,071.65 | 38.47 | #1 61,673.90 | 12.69 | #1 11,565 | 26.53 | 47.09 | |
8,477.00 | 2,25,037.72 | 77.15 | 11,067.00 | 13.95 | 2,568 | 65.50 | 71.85 | |
4,833.00 | 1,83,831.78 | 86.03 | 13,886.20 | 20.34 | 2,138 | 3.28 | 45.42 | |
1,450.00 | 1,17,137.57 | 35.17 | 29,044.60 | 2.24 | 3,870 | -39.18 | 50.74 | |
1,135.20 | 1,14,227.68 | 25.48 | 27,657.90 | 17.64 | 5,026 | -34.90 | 50.68 | |
2,235.00 | 1,02,191.47 | #1 18.62 | 29,038.90 | #1 26.75 | 5,356 | 16.00 | 30.04 | |
1,200.00 | 1,00,160.29 | 31.62 | 35,058.60 | 3.90 | 4,158 | -69.10 | 49.18 | |
2,425.20 | 1,00,159.78 | 48.30 | 14,636.40 | 14.85 | 1,938 | 29.13 | 43.34 | |
1,787.30 | 96,488.57 | 91.23 | 6,867.80 | 22.01 | 890 | #1 123.93 | 61.64 | |
1,622.10 | 93,332.05 | 25.93 | 34,145.20 | 5.56 | 3,503 | 25.21 | 55.68 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
13.82 %
Net Income Growth
-7.98 %
Cash Flow Change
126.97 %
ROE
-17.69 %
ROCE
1.12 %
EBITDA Margin (Avg.)
-11.71 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 262 | 288 | 308 | 387 | 551 | 614 | 687 | 707 | 637 | 548 | 615 | 648 |
| Fixed Assets | 85 | 168 | 172 | 177 | 178 | 200 | 263 | 299 | 267 | 269 | 227 | 220 |
| Current Assets | 91 | 95 | 104 | 182 | 296 | 284 | 310 | 314 | 253 | 242 | 335 | 388 |
| Capital Work in Progress | 65 | 6 | 6 | 4 | 22 | 71 | 57 | 35 | 45 | 2 | 16 | 13 |
| Investments | 3 | 1 | 18 | 12 | 8 | 0 | 0 | 0 | 3 | 0 | 1 | 0 |
| Other Assets | 109 | 113 | 113 | 194 | 344 | 343 | 367 | 373 | 321 | 277 | 372 | 414 |
| Total Equity & Liabilities | 262 | 288 | 308 | 387 | 551 | 614 | 687 | 707 | 637 | 548 | 615 | 648 |
| Current Liabilities | 94 | 109 | 86 | 104 | 156 | 195 | 209 | 207 | 209 | 173 | 212 | 209 |
| Non Current Liabilities | 14 | 24 | 49 | 146 | 145 | 110 | 117 | 128 | 115 | 89 | 44 | 39 |
| Total Equity | 154 | 156 | 173 | 137 | 251 | 309 | 360 | 372 | 313 | 285 | 359 | 401 |
| Reserve & Surplus | 129 | 128 | 142 | 124 | 246 | 295 | 346 | 358 | 301 | 274 | 348 | 392 |
| Share Capital | 2 | 2 | 2 | 2 | 5 | 14 | 14 | 14 | 14 | 14 | 15 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -2 | 2 | -4 | 47 | 6 | -57 | 21 | -4 | 19 | -1 | -10 | 8 |
| Investing Activities | -18 | -13 | 7 | -101 | -97 | -44 | -41 | -26 | -55 | -16 | -0 | -43 |
| Operating Activities | 15 | 4 | 2 | 59 | 90 | 35 | 63 | 43 | 116 | 105 | 41 | 93 |
| Financing Activities | 1 | 10 | -12 | 89 | 12 | -48 | -1 | -22 | -41 | -91 | -51 | -42 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 |
| Promoter | 59.44 % | 59.44 % | 59.44 % | 59.58 % | 59.58 % | 59.58 % | 59.58 % | 59.58 % | 59.58 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.05 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.13 % | 0.35 % |
| DIIs | 0.24 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.05 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.04 % | 0.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 32.86 % | 32.33 % | 33.17 % | 33.98 % | 33.86 % | 33.98 % | 34.06 % | 34.12 % | 33.99 % | 32.28 % | 32.37 % | 32.56 % | 32.47 % | 32.51 % | 31.29 % | 32.31 % | 30.38 % | 29.60 % | 29.76 % | 29.48 % | 28.80 % | 28.33 % | 28.42 % |
| Others | 7.45 % | 8.22 % | 7.39 % | 6.43 % | 6.55 % | 6.43 % | 6.30 % | 6.29 % | 6.42 % | 5.66 % | 5.57 % | 5.38 % | 5.47 % | 5.43 % | 6.59 % | 5.60 % | 5.51 % | 6.29 % | 6.12 % | 6.41 % | 7.09 % | 7.42 % | 7.11 % |
| No of Share Holders | 15,027 | 15,541 | 18,399 | 18,578 | 17,518 | 17,472 | 17,971 | 17,610 | 16,897 | 16,148 | 15,721 | 15,150 | 15,178 | 14,589 | 13,221 | 12,922 | 12,930 | 12,845 | 13,760 | 14,139 | 13,661 | 14,131 | 14,991 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 2.5 | 2.5 | 1.25 | 5 | 2.5 | 1.25 | 1.25 | 1.25 | 2.5 | 3.75 |
| Dividend Yield (%) | 1.05 | 0.91 | 0.59 | 2 | 1.22 | 1.12 | 0.83 | 0.46 | 0.78 | 0.83 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 05 Nov 2019 |  Change Of Name | NA | 05 Nov 2019 | 234.96 | 234.96 |
| 14 Feb 2020 |  Bonus | 2:1 | 13 Feb 2020 | 239.30 | 276.10 |
| 27 Aug 2021 |  Dividend | ₹ 2.50 /share | 25 Aug 2021 | 331.25 | 288.70 |
| 05 Aug 2022 | Dividend | ₹ 1.25 /share | 04 Aug 2022 | 198.80 | 191.30 |
| 02 Sept 2022 |  Extraordinary General Meeting | NA | 02 Sept 2022 | 193.20 | 183.15 |
| 22 Sept 2023 | Dividend | ₹ 1.25 /share | 22 Sept 2023 | 142.65 | 170.55 |
| 06 Aug 2024 | Dividend | ₹ 1.25 /share | 06 Aug 2024 | 166.90 | 243.70 |
| 12 Aug 2024 |  Annual General Meeting | NA | 12 Aug 2024 | 166.90 | 253.90 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 337.75 | 320.45 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 372.85 | 416.85 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 299.95 | 294.05 |
| 06 Aug 2025 | Dividend | ₹ 2.50 /share | 06 Aug 2025 | 294.05 | 360.00 |
| 12 Aug 2025 | Annual General Meeting | NA | 12 Aug 2025 | 294.05 | 346.10 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 356.10 | 346.10 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 267.30 | 277.30 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 328.90 | 328.25 |
| 26 May 2026 | Quarterly Result Announcement | NA | 26 May 2026 | 288.35 | 304.35 |
| 05 Aug 2026 | Dividend | ₹ 3.75 /share | 05 Aug 2026 | 304.35 | 546.75 |
| 11 Aug 2026 | Annual General Meeting | NA | 11 Aug 2026 | 304.35 | 548.50 |
| 11 Aug 2026 | Quarterly Result Announcement | NA | 11 Aug 2026 | 511.70 | 548.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
3 days agoDeclaration Of Voting Results Of The 74Th Annual General Meeting4 days ago
4 days agoShareholder Meeting / Postal Ballot-Scrutinizers Report4 days ago
4 days agoShareholder Meeting / Postal Ballot-Outcome of AGM4 days ago
4 days agoPresentation For Shareholders At 74Th Annual General Meeting (AGM)4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Investor Presentation4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
4 days agoUnaudited Financial Results For Quarter Ended June 30 2026.4 days ago
4 days agoBoard Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - June 30 2026.4 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation5 days ago
5 days agoBoard Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2026.Aug 04, 2026
Aug 04, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 04, 2026
Aug 04, 2026Intimation Regarding Listing Of Equity Shares Of Fermenta Biotech Limited On National Stock Exchange Of India Limited.Jul 31, 2026
Jul 31, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 24, 2026
Jul 24, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 21, 2026
Jul 21, 2026Business Responsibility and Sustainability Reporting (BRSR)Jul 20, 2026
Jul 20, 2026Notice Of The 74Th Annual General Meeting Of Fermenta Biotech Limited To Be Held On August 11 2026.Jul 20, 2026
Jul 20, 2026Reg. 34 (1) Annual Report.Jul 20, 2026
Jul 20, 2026Cessation Of Subsidiary Viz. Fermenta Environment Solutions Private Limited Being A Wholly-Owned Subsidiary.Jul 20, 2026
Jul 20, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2026
Jul 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 17, 2026
Jul 17, 2026Clarification On Price Movement In The CompanyS Shares.Jul 17, 2026
Jul 17, 2026Clarification sought from Fermenta Biotech LtdJul 16, 2026
Jul 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 16, 2026
Jul 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 06, 2026
Jul 06, 2026Approval From Food Safety And Standards Authority Of India (FSSAI) For CompanyS Product Vitamin D3 (Cholecalciferol) - Plant Source.Jul 03, 2026
Jul 03, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 24, 2026
Jun 24, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 22, 2026
Jun 22, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2026
Jun 17, 2026Application To National Stock Exchange Of India Limited For Seeking Approval For Listing And Trading Of The CompanyS Equity Shares.Jun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Jun 08, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
May 27, 2026Corporate Action-Board approves DividendMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2026
May 26, 2026Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI Listing RegulationsMay 26, 2026
May 26, 2026Board Meeting Outcome for Annual General Meeting Financial Results And DividendMay 26, 2026
May 26, 2026Audited Financial Statements (Standalone And Consolidated) For Quarter & Year Ended March 31 2026 Along With Auditors Report Thereon Along With Information For AGM And DividendMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 25, 2026
May 25, 2026Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Consideration Of Final Equity Dividend If Any.May 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 28, 2026
Apr 28, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 28, 2026
Apr 28, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2026
Apr 28, 2026Admission Of Companys Shares By NSE Under Permitted To Trade Category On National Stock Exchange (Capital Market Segment).Apr 21, 2026
Apr 21, 2026Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.03% | 0 | 0.00% | 0.01% |
Technical Indicators
RSI(14)
Neutral 46.64
ATR(14)
Less Volatile 31.93
STOCH(9,6)
Neutral 40.56
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -10.31
ADX(14)
Strong Trend 29.82
UO(9)
Bearish 39.93
ROC(12)
Downtrend And Accelerating -0.35
WillR(14)
Oversold -91.28
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
